is the company’s largest but also the slowest-growing compared to its other business lines of wound management and sports medicine. Shareholders are said to have concerns over Smith & Nephew’s ...
Sports Medicine & ENT and Advanced Wound Management. Founded in Hull, UK, in 1856, we now operate in around 100 countries, and generated annual sales of $5.8 billion in 2024. Smith+Nephew is a ...
Sports Medicine & ENT and Advanced Wound Management. Founded in Hull, UK, in 1856, we now operate in around 100 countries, and generated annual sales of $5.8 billion in 2024. Smith+Nephew is a ...
Sports Medicine & ENT and Advanced Wound Management. Founded in Hull, UK, in 1856, we now operate in around 100 countries, and generated annual sales of $5.8 billion in 2024. Smith+Nephew is a ...
Corient Private Wealth LLC grew its position in Smith & Nephew plc (NYSE:SNN – Free Report) by 6.8% in the fourth quarter, ...
Natixis Advisors LLC boosted its holdings in Smith & Nephew plc (NYSE:SNN – Free Report) by 59.9% during the fourth quarter, ...
Detailed price information for Smith & Nephew Snats ADR (SNN-N) from The Globe and Mail including charting and trades.
Smith & Nephew plc engages in the development ... Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce that the latest annual report from the Australian Orthopaedic Association National Joint Replacement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results